SFSIG
IDIX

San Francisco Sentry Investment Group’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

San Francisco Sentry Investment Group’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-4,750
Closed -$29K – 696
2014
Q1 		$29K Hold
4,750
– – 0.01% 418
2013
Q4 		$28K Hold
4,750
– – 0.01% 391
2013
Q3 		$25K Hold
4,750
– – 0.01% 391
2013
Q2 		$17K Buy
+4,750
New +$19.4K 0.01% 428

Other funds holding IDIX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

San Francisco Sentry Investment Group's IDIX Position: Q2 2014 in Review

San Francisco Sentry Investment Group sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q2 2014, closing a stake of 4,750 shares — an estimated $29K sold.

San Francisco Sentry Investment Group first reported a position in IDIX in Q2 2013 and held it in 4 quarters. The position peaked at $29K in Q1 2014. 131 funds tracked by Wall St. Rank hold IDIX as of Q2 2014.

  • San Francisco Sentry Investment Group reported no remaining IDENIX PHARMACEUTICALS INC position as of Q2 2014 after selling out during the quarter.
  • San Francisco Sentry Investment Group sold 4,750 IDENIX PHARMACEUTICALS INC shares in Q2 2014, an estimated $29K.
  • San Francisco Sentry Investment Group first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 4 quarters.
  • San Francisco Sentry Investment Group's IDENIX PHARMACEUTICALS INC position peaked at $29K in Q1 2014.
  • 131 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q2 2014.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2014, filed 18 Jul 2014.